Medical Pharmacology Chapter 36: Antiviral Drugs
Viral Genome and Virus Classification
The viral genome regulates expression of proteins enabling genome replication.1
The characteristics of those pathways responsible for synthesis of early viral proteins are intimately associated with both chemical nature and strandedness of genomic DNA or RNA.
Viruses that utilize single-strand RNA can be subcategorized into two groups.
Some viruses contain the "sense" RNA strands containing coding structures that may be directly translated into viral proteins.
In this case the strand is described as the positive (or plus) strand.
Other viruses package the complementary base sequence or "anti-sense" strand.
This latter type describes the negative (or minus) strand. Initiation of replication cycles are different between these two groups.1
Strandedness as well as other virus genome characteristics represents one of several bases of viral classification.2
Other virus genomic properties in addition to strandedness include:
Genomic size in kilobases (kb) or kilobase pairs (kpb)
Whether the genome is arranged linearly or circularly
|
Genomic segments (number and size)
Nucleotide sequence
G + C (guanine + cytosine) content
|
|
Presence of special aspects such as:
Tandem repeats are described by successive identical (or nearly identical) nucleotide (DNA) repeat units.7
A tandem repeat is defined as a pattern (e.g. in DNA) of one or more nucleotides repeated with repetitions adjacent.
For example: ATTCG ATTCG ATTCG where the sequence ATTCG is found repeated three times.
|
|
However, there may be variation in both length of repeat units as well as length of the whole repeats making absolute classification challenging.
Large repeat units (largest) are described as "satellites."
The term satellite is derived from centrifugation of DNA in density gradients.
In this case major bands form; however, smaller bands which differ in CG/AT content are also described.
The smaller bands likely occur due to large "monotonous" repeats.
The term "minisatellites" described shorter tandem repeats 10 to 60 nucleotide repeats); whereas, "microsatellites" exhibit very short repeat units of the order of 1-5 bp.7
The Epstein-Barr virus (EBV) genome exhibits an unusually high content of repetitive sequences.5
|
|
This virus is characterized by linear genomic DNA on the order of 170 kilobases (kb) with a high content of these repetitive sequences.
Tandem repeats are common among latent EBV genes, i.e. those genes expressed in the latent viral cycle.5
The EBV genome has been used even as a model for repetitive sequences within eukaryotic cell chromosomes.
In the case of EBV repeat sequences have been described at several internal as well as terminal regions.6
Directionality and molecular biology refers to the end-to-end chemical orientation of a single nucleic acid strand.
This is based on a chemical convention of naming nucleotide sugar-ring carbon atoms using numbers and giving rise to a 5' end (five prime end) and a 3' end (three prime end). The term upstream as it relates to genes and protein regulatory binding sites refers to "towards the 5'-end or downstream i.e. towards the 3'-end. See figures below.
|
|
|
|
Most eukaryotic mRNAs contain a special blocked nucleotide structure at their 5' end, named the cap structure.12
Analysis of cellular and viral mRNAs resulted in a generalized cap structure, which in the case of human respiratory syncytial virus, consists of a 7-methyl guanosine links to an unmethylated guanosine via a 5'-5' pyrophosphate linkage formed utilizing the α and β phosphates of GTP.
The complete cap structure is m7G(5')ppp(5')Gp, devoid of ribose 2'-O-methylation. The capping process, including methylation, is associated with transcription.12
|
|
|
|
|
5'-terminal covalently linked protein2
One of the early examples of a virus containing a protein attached to the 5' terminal of his DNA is the hepatitis B virus.14
The hepatitis B virus DNA is a small circular molecule, partially double-stranded.
There is, moreover, a single-stranded portion of the length 15-50% of the circle links in different molecules.
Purification studies suggested that the HBV DNA contained a tightly attached protein since DNA could not be removed from aqueous solution without prior protease digestion.
These observations from 1980 followed earlier findings of proteins associated with the 5' terminal of linear nucleic acids tightly bound to adenoviruses, enteroviruses, and B. subtilis phage ϕ29.14
In the case of adenovirus, a 5' prime terminal precursor protein serves as a primer for the start of viral DNA replication.15
The mechanism involves covalent binding of the first nucleotide in the DNA chain with this precursor protein remaining covalently bound to the 5' terminal of viral DNA.
Upon virion maturation the precursor protein is cleaved to the terminal 5' protein.
The 5' virion terminal protein is thus derived from the carboxyl (COOH) terminus of this precursor protein.
The mature virion terminal 5' protein enables viral DNA to circularize, process which is both protease-sensitive and dependent on noncovalent interactions.
In this case, the covalent linkage between DNA and the 5' terminal protein is mediated by a phosphodiester bond between the β-hydroxyl group of the terminal protein' s serine residue and the 5'-hydroxyl of the terminal deoxycytosine residue.15
VPg: The presence of genome-linked viral proteins was initially identified approximately 40 years ago in studies of polioviral RNA.16,17
|
|
Detailed chemical analysis of the poliovirion indicated that the 5'-terminal end of the virion RNA exhibited the following structure: protein-pU-U-A-A-A-A-C-A-G. 16
The authors suggested that the protein-nucleotide structure function as a primer for initiation of poliovirus RNA synthesis.
This primer activity depends on the protein first becoming uridylylated which provides a free hydroxyl, allowing initial interaction with viral encoded RNA-dependent RNA polymerase.
VPg uridylylation is catalyzed by viral RNA-dependent RNA polymerase.
Uridylylation of VPg is thus a required step in poliovirus genome replication. 16, 17,18
The genome of herpes simplex virus (HSV) exhibits isomerization. HSV genomes are described as linear molecules composed of both long (L) and short (S) segments.19
Each segment is associated with unique sequences designated UL and US. (U for "unique")
Genomic replication occurs at three origins, one localized in UL (OriL) and two (diploid) localized in the short repeating region (OriS).
Characteristics of replication intermediates suggested a "rolling circle mechanism" responsible for HSV DNA synthesis.
Furthermore, the L and S segments invert relative to each other, resulting in four equimolar genomic isomers.
Isomers (two) may occur by cleavage of concantemers at alternative L- S junctions with remaining isomers occur due to homologous recombination between sequences in the large repeated regions of DNA that flank L-S junctions.
Isomerization might be associated with formation of circular replication templates derived from linear virion DNA.19
|
|
|
Almost all fully processed eukaryotic mRNA exhibit a poly(A) tail located at the 3' end.21
This poly(A) appears important in nearly all aspects of mRNA metabolism.
Proposed functions include:
Enhancement of mRNA stability
Increased mRNA translational efficiency and
Participation in mRNA transport from the nucleus to the cytoplasm.
The underlying polyadenylation involves activities beyond addition of poly(A) tails to mRNAs.21
|
This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information. Medical or other information thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals. |